Literature reference · Endocrinology
Tirzepatide for Obesity Treatment and Diabetes Prevention.
PubMed · Retrieved 2026-10-13
Bibliographic record: The New England journal of medicine (2025 Mar 06). PMID 39536238. DOI 10.1056/NEJMoa2410819.
Reference details
- Authors
- Ania M Jastreboff; Carel W le Roux; Adam Stefanski; Louis J Aronne; Bruno Halpern; Sean Wharton; John P H Wilding; Leigh Perreault; Shuyu Zhang; Ramakrishna Battula; Mathijs C Bunck; Nadia N Ahmad; Irina Jouravskaya; SURMOUNT-1 Investigators
- Journal
- The New England journal of medicine
- Publication date
- 2025 Mar 06
- PMID
- 39536238
- DOI
- 10.1056/NEJMoa2410819
- Volume
- 392
- Issue
- 10
- Pages
- 958
- Language
- eng
- Publication types
- Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
- MeSH subjects
- Adult; Female; Humans; Male; Middle Aged; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Obesity; Prediabetic State; Tirzepatide; Weight Loss; Glucagon-Like Peptide-1 Receptor Agonists; Body Weight; Gastrointestinal Diseases; Dose-Response Relationship, Drug
Citation
Indexed subjects
Access and reuse
Sources and reuse
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-05-18. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.